Considerações sobre revisões sistemáticas de testes diagnósticos by Atallah, Álvaro Nagib et al.
Sao Paulo Med J. 2012; 130(5):279-81     279
EDITORIAL
Remarks about systematic reviews of diagnostic tests
Considerações sobre revisões sistemáticas de testes diagnósticos
Álvaro Najib AtallahI, Andrea PuchnickII, Daniel WuIII, David Carlos ShigueokaIV, Gianni Mara Silva dos SantosV,  
Hernani Pinto de Lemos JúniorVI, José Eduardo MourãoVII, Wagner IaredVIII
Brazilian Cochrane Center, São Paulo, Brazil
From the start of the second half of the 20th century, the evolution of medicine was seen to 
be accelerating, and the new millennium began with a fast pace. Doctors and other health pro-
fessionals cannot survive unless they are up to date with the constant changes imposed by tech-
nology, especially in big cities.
Over the last few decades, the avalanche of new drugs and modern methods of treatment 
has encouraged doctors to look for faster ways to follow these changes, as well as ways to verify 
the true efficacy of these new interventions. All of these changes led to evidence-based medi-
cine, which has subsequently become known as evidence-based healthcare, when other health-
care professionals are included in this.
Evidence consists of nothing more than the results of assessments through scientific studies 
with reproducible methodological quality (for all the data described in the work). This is pos-
sible in intervention studies on high-prevalence diseases because they present large numbers of 
participants. However, in cases of low-prevalence diseases, the results give rise to doubts. This 
has led to the use of systematic reviews, since these are able to fulfill the need to evaluate inter-
vention studies. However, this is only possible when studies are designed to have similar objec-
tives and interventions and their methodological quality can be assessed. In a systematic review, 
it is desirable and often feasible to obtain the sum of statistical data from several studies, which 
is called meta-analysis.
More recently, the same need has arisen in the field of diagnostics. The evolution of diagnos-
tic equipment and the emergence of new laboratory kits with promises of faster, more accurate 
and less invasive diagnostic methods has been widely broadcasted in the media. This directly 
influences patients’ opinions, and affects the people responsible for doing the examinations and 
governments. Patients obviously want to have access to the best examination that there is, while 
professionals and governments want to make sure that these new tests really are superior to the 
existing ones, so that the possibly high financial investment can be justified. Therefore, system-
atic reviews on diagnostic accuracy studies are considered to be of great relevance.
Given the lack of consensus on the most appropriate way of conducting the systematic 
review method, the Cochrane Collaboration, a pioneer in implementing systematic reviews 
on intervention studies, decided to disseminate and encourage the development of systematic 
reviews on accuracy studies by creating a section aimed only at reviews on diagnostic accu-
racy studies. This new section forms part of the RevMan (Review Manager) software, which the 
Cochrane Collaboration maintains in order to guide the elaboration of reviews and enable pro-
duction of meta-analysis whenever possible. This brilliant initiative has caught the attention of 
many researchers and has encouraged them to work in this field, but just as in any other move-
ment in its initial phase, several unresolved issues still hinder the work.
The tools for assessing the quality of individual diagnostic accuracy studies are different 
from those applied in intervention studies. This has generated great confusion among research-
ers and among editorial boards evaluating such studies. There are several published system-
atic reviews on accuracy studies that are full of inappropriate terms and were methodologically 
designed as if they were intervention studies. Furthermore, there is a lack of significant accuracy 
values, such as sensitivity, specificity and predictive values. 
IMD, PhD. Full Professor and Head, Discipline 
of Emergency Medicine and Evidence-
Based Medicine, Escola Paulista de Medicina, 
Universidade Federal de São Paulo (EPM-
Unifesp), and Director of the Brazilian Cochrane 
Center, São Paulo, Brazil. Scientific Director of 
Associação Paulista de Medicina (APM), São 
Paulo, Brazil.
IIBSc. Professor and Coordinator of Educational 
and Research Support, Department of 
Diagnostic Imaging, Escola Paulista de Medicina, 
Universidade Federal de São Paulo (EPM-
Unifesp), São Paulo, Brazil.
IIIUndergraduate Student of Medicine, Escola 
Paulista de Medicina, Universidade Federal de 
São Paulo (EPM-Unifesp), São Paulo, Brazil.
IVMD, PhD. Associate Professor, Department of 
Diagnostic Imaging, Escola Paulista de Medicina, 
Universidade Federal de São Paulo (EPM-
Unifesp), São Paulo, Brazil.
VMSc. Statistician, Universidade Federal de São 
Paulo (Unifesp), São Paulo, Brazil.
VIMD, PhD. Research Assistant, Discipline of 
Emergency Medicine and Evidence-Based 
Medicine, Escola Paulista de Medicina, 
Universidade Federal de São Paulo (EPM-
Unifesp), and Brazilian Cochrane Center, São 
Paulo, Brazil.
VIIMD, PhD. Associate Professor of Radiology, 
Department of Medicine, Universidade Federal de 
São Carlos (UFSCAR), São Carlos, São Paulo, Brazil.
VIIIMD, PhD. Research Assistant, Brazilian 
Cochrane Center, São Paulo, Brazil.
EDITORIAL | Atallah AN, Puchnick A, Wu D, Shigueoka DC, Santos GMS, Lemos Júnior HP, Mourão JE, Iared W
280     Sao Paulo Med J. 2012; 130(5):279-81
REFERENCES
1. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-
based medicine: how to practice and teach EBM. New York: Churchill 
Livingstone; 1997. 
2. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of 
QUADAS: a tool for the quality assessment of studies of diagnostic accuracy 
included in systematic reviews. BMC Med Res Methodol. 200310;3:25.
3. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool 
for the quality assessment of diagnostic accuracy studies. Ann Intern 
Med. 2011;155(8):529-36.
4. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM; Cochrane Diagnostic 
Test Accuracy Working Group. Systematic reviews of diagnostic test 
accuracy. Ann Intern Med. 2008;149(12):889-97.
Articles cannot and should not be written for the sole purpose of having them read and evaluated by researchers and bureaucrats. 
The quality of tests needs to be defined, as does their performance, in terms of superiority, inferiority or resemblance in relation to 
preexisting tests. Also, this must be carried out honestly in presenting the data. The way to show evidence is not to present unnamed 
percentage indicators and let the reader do the math. All the data presented must be named, so that the conclusion of the study can be 
enhanced through significant and intelligible results, and not through personal opinions. 
Whenever two or more studies with similar designs evaluating the accuracy of a particular test within the same patient spectrum 
are found in a systematic review, it is possible to obtain summary results, i.e. a meta-analysis, which must be expressed in terms of sen-
sitivity and specificity with the respective confidence intervals. This provides the possibility of inferring additional data, such as posi-
tive and negative predictive values and likelihood ratios.
One important difference between systematic reviews on accuracy studies and on intervention studies is the quality assessment. 
To assess the quality of each case, Sackett et al. suggested that four questions needed to be answered: 1) Is there any blinding of the 
results between the index test and the standard reference? 2) Is the patient spectrum adequate? 3) Is there independence in applying the 
standard reference? 4) Is the standard reference applied to the entire sample?1 However, experience has shown that these four questions 
were insufficient to assess the quality of many studies.
QUADAS (Quality Assessment of Diagnostic Accuracy Studies) is a tool that was developed to assess other relevant issues.2 It con-
sists of 14 questions detailing the characteristics of the patient selection (patient spectrum); partial verification bias (whether the whole 
sample was subjected to the standard reference); differential verification bias (whether more than one reference standard was applied); 
blinding of the results; reference standard and index test characteristics; and losses in the study, From this, the reporting and internal 
and external validity can be evaluated. However, there were still situations in which the questions of QUADAS were not applicable, and 
others in which further questions needed to be included.
QUADAS-2 is now available. This is a tool that adapts to the type of test and disease that is to be evaluated and consists of four key 
domains: 1) patient selection; 2) index test; 3) reference standard; and 4) flow and timing. Each domain assesses the risk of bias and the 
first, second and third domains also evaluate the study applicability. This tool basically involves drawing up a hypothetical ideal model 
for an accuracy test, so that a specific test can be assessed for a specific patient spectrum. Relevant questions are asked in order to com-
pare the idealized test with each study that has been found through the search strategy.3
Whenever diagnostic accuracy studies under similar clinical and evaluation conditions are grouped, one concern that always 
comes up is the heterogeneity of the results. While heterogeneity is an exception in intervention studies, it is the rule in diagnos-
tic accuracy studies.4 The source of the heterogeneity is not always clear, although it is possible that the patient spectrum at different 
research sites may be the main factor in most cases. Nevertheless, these sources must of course be evaluated individually. In systematic 
reviews on intervention studies, one or more studies with very heterogeneous results may be excluded from the meta-analysis. Because 
the patient spectrum, target condition, evaluated test and reference standard are the same in diagnostic accuracy studies, this kind of 
exclusion should not take place in systematic reviews on such studies.
For this reason, choosing the best way to mathematically group the results from several accuracy studies has led to a dead end. 
For non-heterogeneous studies, because there is no randomization in quality accuracy studies, grouping them is a valid option for 
performing meta-analysis. However, whenever heterogeneity is present, this factor must be taken into account. Comparison of differ-
ent individual tests in a systematic review can be done visually using a receiver-operating characteristic (ROC) curve, or using a for-
est plot in situations in which sensitivity and specificity values with their respective confidence intervals are available.4 The Cochrane 
Collaboration has suggested that the hierarchical summary receiver operating characteristic (HSROC) model5 or the bivariate model6 
should be used to obtain summary estimates of sensitivity and specificity with their respective confidence intervals.
We are looking forward to the promised update from RevMan for accuracy studies in order to facilitate fulfillment and standard-
ization of the results and conclusions among authors. 
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